Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 72.80
+0.65 (0.90%)
Aug 12, 2026, 11:55 AM CET
Apotea AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 103.5 | 30.6 | 27.3 | 19.1 | 18.2 | 81.7 |
Cash & Short-Term Investments | 103.5 | 30.6 | 27.3 | 19.1 | 18.2 | 81.7 |
Cash Growth | 50.00% | 12.09% | 42.93% | 4.95% | -77.72% | - |
Accounts Receivable | 375.1 | 355.4 | 358.8 | 289.4 | 246 | 231.6 |
Other Receivables | 101.3 | 62 | 47.9 | 47.1 | 37.4 | 43.6 |
Total Trade Receivables | 476.4 | 417.4 | 406.7 | 336.5 | 283.4 | 275.2 |
Inventory | 855.3 | 651.9 | 562.3 | 410.1 | 390 | 339.6 |
Other Current Assets | 27 | 18.6 | 25.1 | 15.8 | 29.7 | 17.1 |
Total Current Assets | 1,462 | 1,119 | 1,021 | 781.5 | 721.3 | 713.6 |
Net Property, Plant & Equipment | 713.9 | 812.6 | 546.9 | 490.8 | 462.4 | 289.1 |
Other Intangible Assets | 12.3 | 14.1 | 18.1 | 23.7 | 4.1 | 1.6 |
Goodwill | 32.3 | 30.5 | 32 | 32.5 | 57.5 | 5.5 |
Long-Term Investments | 1.5 | 1.5 | 7.7 | 7.8 | 7.2 | 19 |
Other Long-Term Assets | 3.6 | 3.3 | 1.6 | - | - | - |
Total Assets | 2,226 | 1,981 | 1,628 | 1,336 | 1,253 | 1,029 |
Accounts Payable | 769.3 | 584.1 | 559.4 | 546.1 | 463.8 | 437.4 |
Accrued Expenses | 158.1 | 130.9 | 140 | 77.1 | 78.2 | 76.5 |
Short-Term Debt | - | 21.6 | 79.6 | 66.9 | 111.8 | - |
Current Portion of Leases | 217.6 | 248.8 | 110.7 | 44.7 | 41.9 | 21.3 |
Other Current Liabilities | 56 | 74.3 | 50.1 | 21.8 | 20.7 | 26.5 |
Total Current Liabilities | 1,045 | 871.5 | 880.8 | 756.7 | 716.4 | 561.7 |
Long-Term Leases | 61.7 | 60.6 | 51.7 | 150.1 | 179 | 123.6 |
Other Long-Term Liabilities | 0.3 | 0.3 | 0.2 | 4.6 | 2.1 | 2.3 |
Total Long-Term Liabilities | 217.9 | 249.1 | 110.9 | 154.7 | 181 | 126 |
Total Liabilities | 1,263 | 1,121 | 991.7 | 911.4 | 897.5 | 687.7 |
Common Stock | 0.5 | 0.5 | 0.5 | 0.1 | 0.1 | 0.1 |
Additional Paid-in Capital | 14.6 | 14.7 | 14.7 | 15.1 | 15.1 | 15.1 |
Accumulated Other Comprehensive Income | -2.1 | -3.8 | -2.2 | -0.2 | - | - |
Retained Earnings | 934 | 832.6 | 602.2 | 388.7 | 312.3 | 325.9 |
Total Common Shareholders' Equity | 947 | 844 | 615.2 | 403.7 | 327.5 | 341.1 |
Minority Interest | 15.8 | 15.9 | 20.8 | 21.3 | 27.5 | - |
Shareholders' Equity | 962.8 | 859.9 | 636 | 425 | 355.1 | 341.1 |
Total Liabilities & Equity | 2,226 | 1,981 | 1,628 | 1,336 | 1,253 | 1,029 |
Total Debt | 279.3 | 331 | 242 | 261.7 | 332.7 | 144.9 |
Net Cash (Debt) | -175.8 | -300.4 | -214.7 | -242.6 | -314.5 | -63.2 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.69 | -2.88 | -2.09 | -2.38 | -154.28 | -31.00 |
Book Value | 947 | 844 | 615.2 | 403.7 | 327.5 | 341.1 |
Book Value Per Share | 9.09 | 8.11 | 6.00 | 3.96 | 160.66 | 167.33 |
Tangible Book Value | 902.4 | 799.4 | 565.1 | 347.5 | 265.9 | 334 |
Tangible Book Value Per Share | 8.67 | 7.68 | 5.51 | 3.41 | 130.44 | 163.85 |